50 related articles for article (PubMed ID: 11115538)
1. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells.
Zhang H; Ozaki I; Mizuta T; Yoshimura T; Matsuhashi S; Eguchi Y; Yasutake T; Hisatomi A; Sakai T; Yamamoto K
Cancer Sci; 2004 Nov; 95(11):878-86. PubMed ID: 15546505
[TBL] [Abstract][Full Text] [Related]
4. Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-beta receptor type II.
Zhao W; Kobayashi M; Ding W; Yuan L; Seth P; Cornain S; Wang J; Okada F; Hosokawa M
Cancer Immunol Immunother; 2002 Sep; 51(7):381-8. PubMed ID: 12192538
[TBL] [Abstract][Full Text] [Related]
5. Selenoprotein P mRNA expression in human hepatic tissues.
Li CL; Nan KJ; Tian T; Sui CG; Liu YF
World J Gastroenterol; 2007 Apr; 13(16):2363-8. PubMed ID: 17511039
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.
Bacigalupo ML; Manzi M; Rabinovich GA; Troncoso MF
World J Gastroenterol; 2013 Dec; 19(47):8831-49. PubMed ID: 24379606
[TBL] [Abstract][Full Text] [Related]
7. Increased ΤGF-β3 in primary biliary cirrhosis: an abnormality related to pathogenesis?
Voumvouraki A; Koulentaki M; Tzardi M; Sfakianaki O; Manousou P; Notas G; Kouroumalis E
World J Gastroenterol; 2010 Oct; 16(40):5057-64. PubMed ID: 20976842
[TBL] [Abstract][Full Text] [Related]
8. Up-Regulation of ninjurin expression in human hepatocellular carcinoma associated with cirrhosis and chronic viral hepatitis.
Kim JW; Moon AR; Kim JH; Yoon SY; Oh GT; Choe YK; Choe IS
Mol Cells; 2001 Apr; 11(2):151-7. PubMed ID: 11355694
[TBL] [Abstract][Full Text] [Related]
9. Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.
Zaidi S; Amdur R; Xiang X; Yu H; Wong LL; Rao S; He AR; Amin K; Zaheer D; Narayan RK; Satapathy SK; Latham PS; Shetty K; Guha C; Gough NR; Mishra L
Genes Cancer; 2022; 13():9-20. PubMed ID: 35677836
[TBL] [Abstract][Full Text] [Related]
10. FGFR4 and TGF-β1 expression in hepatocellular carcinoma: correlation with clinicopathological features and prognosis.
Chen Z; Xie B; Zhu Q; Xia Q; Jiang S; Cao R; Shi L; Qi D; Li X; Cai L
Int J Med Sci; 2013; 10(13):1868-75. PubMed ID: 24324363
[TBL] [Abstract][Full Text] [Related]
11. CD133: a stem cell biomarker and beyond.
Li Z
Exp Hematol Oncol; 2013 Jul; 2(1):17. PubMed ID: 23815814
[TBL] [Abstract][Full Text] [Related]
12. Genetics of hepatocellular carcinoma.
Teufel A; Staib F; Kanzler S; Weinmann A; Schulze-Bergkamen H; Galle PR
World J Gastroenterol; 2007 Apr; 13(16):2271-82. PubMed ID: 17511024
[TBL] [Abstract][Full Text] [Related]
13. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
14. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M
Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
[TBL] [Abstract][Full Text] [Related]
17. Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.
Calabrese F; Valente M; Giacometti C; Pettenazzo E; Benvegnu L; Alberti A; Gatta A; Pontisso P
J Gastroenterol Hepatol; 2003 Nov; 18(11):1302-8. PubMed ID: 14535988
[TBL] [Abstract][Full Text] [Related]
18. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
Murata M; Yoshida K; Yamaguchi T; Matsuzaki K
World J Gastroenterol; 2014 Nov; 20(41):15018-27. PubMed ID: 25386050
[TBL] [Abstract][Full Text] [Related]
19. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.
Yamaguchi T; Yoshida K; Murata M; Matsuzaki K
World J Gastroenterol; 2014 Sep; 20(35):12381-90. PubMed ID: 25253939
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
